The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's MEDWATCH program (800-FDA-1088). If you have reported an interesting preventable ADR to MEDWATCH, please consider sharing the account with our readers.
In 2004, ISMP is celebrating the 10th anniversary of its incorporation as a nonprofit organization. The Institute represents more than 20 years of experience in helping health care practitioners keep patients safe, and continues to lead efforts to improve the medication use process.
Get full access to this article
View all access options for this article.
References
1.
NebekerJ.R., BarachP., SamoreM.H.Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting. Ann Intern Med.2004; 140: 795–801.
2.
CheungA.Y.Y., FantusI.G.Thiazolidinedione-induced congestive heart failure. Ann Pharmacother.2004; 38: 817–20.
